2025
Cenobamate and pregnancy: A-single level 4 epilepsy center experience
Jimenez A, Toghramadjian I, Okafor C, Hanin A, Zhou X, Dorotan M, Nuthalapati P, Sakya S, Hirsch L, Altalib H, Lazorwitz A, Herlopian A. Cenobamate and pregnancy: A-single level 4 epilepsy center experience. Epilepsy & Behavior 2025, 169: 110440. PMID: 40318387, DOI: 10.1016/j.yebeh.2025.110440.Peer-Reviewed Original ResearchConceptsConcentration-to-dose ratioPost-partum periodUnintended pregnancyContraceptive methodsSingle-center retrospective chart reviewFemales of childbearing ageEarly-term birthPrevent unintended pregnancyAdult female patientsDrug level monitoringMonths of agePre-conceptual counsellingElective terminationSpontaneous miscarriagePregnancy outcomesCongenital malformationsFemale patientsHormonal contraceptionChildbearing ageMedical comorbiditiesCenobamatePregnancyContraceptive usePharmacokinetic profilePatients
2008
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization
Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertility And Sterility 2008, 89: 1694-1701. PMID: 18440515, PMCID: PMC2601677, DOI: 10.1016/j.fertnstert.2007.05.055.Peer-Reviewed Original ResearchConceptsNondonor IVF cyclesClinical pregnancyCycle cancellationLive birthsGonadotropin useIVF cyclesSpontaneous miscarriageOvarian reserve statusOvarian hyperstimulation resultsHigh gonadotropinsOvarian stimulationFertilization cyclesIVF outcomesOocyte yieldWorse prognosisRetrospective studyIVF centerImproved outcomesAggressive approachMAIN OUTCOMEPregnancyIVFHigher likelihoodBirthOutcomes
2002
Should patients with polycystic ovarian syndrome be treated with metformin?
Seli E, Duleba AJ. Should patients with polycystic ovarian syndrome be treated with metformin? Human Reproduction 2002, 17: 2230-2236. PMID: 12202407, DOI: 10.1093/humrep/17.9.2230.Peer-Reviewed Original ResearchConceptsPolycystic ovarian syndromeTreatment of PCOSInsulin-lowering agentsOvarian syndromePathogenesis of PCOSType 2 diabetes mellitusPromising therapeutic profileEarly spontaneous miscarriageOral antihyperglycaemic agentsInsulin-sensitizing drugsType 2 diabetesRisk of developmentImportant aetiologic factorPlasminogen activator inhibitorSerum lipidsDiabetes mellitusCardioprotective effectsAetiologic factorsAntihyperglycaemic agentsInsulin resistanceSpontaneous miscarriageMetforminTherapeutic profileActivator inhibitorTreatmentDetection and Therapeutic Approaches to Age-Related Infertility
Sharara F, Scott R, Seifer D. Detection and Therapeutic Approaches to Age-Related Infertility. 2002, 24-38. DOI: 10.1007/978-3-642-87690-5_3.Peer-Reviewed Original Research
1996
Recurrent Pregnancy Loss
Arici A, Bukulmez O. Recurrent Pregnancy Loss. 1996, 119-133. DOI: 10.1007/978-3-642-60961-9_12.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply